Joseph Zabner is a Respiratory physician affiliated with University of Iowa. OpenAlex indexes 289 publications with 23,835 citations (h-index 80); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Hawkins Dr
Iowa City, IA 522421009
Telephone
319-356-4187Registry record last updated 19 Dec 2007.
Clinical trials
- Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Sponsor: Joseph Zabner
- Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects
Sponsor: Joseph Zabner
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
77.6%Other respiratory system products32.8%Trikafta100%Part D<11 patientsbeta2-Adrenergic Agonist22.4%Albuterol Sulfate Hfa100%Part D<11 patients+ 1 more class in this area
Anti-infectives
22.4%Fluoroquinolone Antibacterial22.4%Levofloxacin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
12 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions
Proceedings of the National Academy of Sciences
2019 - pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37
Proceedings of the National Academy of Sciences
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Perlman, MD
University of Iowa
Mohammed Milhem, MBBS
University of Iowa
Lawrence Hunsicker, MD
University of Iowa
Michael Abramoff, MD, PhD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”